BIIB vs CNM · P/E 21, rev $9.89B vs P/E 21, rev $7.65B
Biogen Inc (BIIB) versus Core & Main Inc (CNM) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Core & Main Inc (CNM) is a industrial distribution company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CNM revenue for 2026-02-01 was $7.65B. Net income was $441.0M. Revenue was up 2.8% from 2025-02-02 to 2026-02-01. CNM currently screens at market cap $9.63B and trailing P/E 21.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CNM currently screens at market cap $9.63B and trailing P/E 21.4.
Not investment advice. Open the BIIB and CNM stock pages for the full models.
Not investment advice.